1st Quarter - Termination
MANATT, PHELPS, AND PHILLIPS for NEKTAR THERAPEUTICS
Client
Income
$14,000
Expenses
—
Terminated
Mar 31, 2020
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
FDA oversight of certain pain reliever products
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK QUINN | Dep. COS and Counselor to the Vice President, COS to the VP and Assistant to President, Counsel to the President |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.